Xu, B., Liu, Q., Guo, X., Jiang, J., Wang, S., Liu, T., Ding, J. (2026). Surufatinib for advanced or metastatic chemotherapy-refractory thymic epithelial tumor: A single-arm, single-center, phase II study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8119